As transcatheter aortic valve replacement becomes a more dominant treatment option
across all risk profiles, the frequency of encountering patients with multivalvular disease will …

Multivalvular disease (MVD) is common among patients with valvular disease, and has a
complex pathophysiology dependent on the specific combination of valve lesions. Diagnosis …

Background Mixed valvular disease (MVD), mitral regurgitation (MR) from pre‐existing
disease in conjunction with paravalvular leak (PVL) following transcatheter aortic valve …

Background Utilization of transcatheter aortic valve replacement (TAVR) has expanded from
high-risk patients to intermediate-and select low-risk candidates with severe aortic stenosis …

Multivalvular heart disease is not an uncommon situation, but the paucity of data for each
specific situation does not allow the proposal of a standardised, evidence-based …

Aims Multivalvular disease is of increasing concern in elderly patients undergoing
transcatheter aortic valve replacement (TAVR). The objective of the present analysis was to …

Background MAVD, defined as severe aortic stenosis with moderate or severe aortic
regurgitation, is frequently encountered in clinical practice. However, the data regarding …

Mixed aortic valve disease (MAVD), defined by the concurrent presence of aortic stenosis
(AS) and insufficiency is frequently seen in patients who have undergone transcatheter …

Aortic stenosis (AS) may present frequently combined with other valvular diseases or mixed
with aortic regurgitation, with peculiar physio-pathological and clinical implications. The …

BACKGROUND: Transcatheter aortic valve implantation (TAVI) is an alternative treatment
option for patients with aortic stenosis deemed high risk or unsuitable for aortic valve …